Concepedia

Rodney L. Decker

RL

3

Publications

52

Citations

3

H-Index

2012

Active since

Affiliations

Eli Lilly (United States)(Current)

Rodney L. Decker is an author at Eli Lilly (United States) specializing in radiation oncology, neoadjuvant therapy, and health sciences.

ORCID

Top concepts

Publications per year

2012–2023

3

Publications

3

A Phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma

Eddy S. Yang, Éric Deutsch, Mehmet Altan et al. · Radiotherapy and Oncology · 2021 · 24 citations

, , +8

Phase I study of enzastaurin and bevacizumab in patients with advanced cancer: safety, efficacy and pharmacokinetics

Nwabundo Nwankwo, Zhe Zhang, Ting Wang et al. · Investigational New Drugs · 2012 · 17 citations · Full text

Microsampling in Pediatric Studies: Pharmacokinetic Sampling For Baricitinib (Olumiant™) in Global Pediatric Studies

Enaksha Wickremsinhe, Rodney L. Decker, Lisa B Lee et al. · Bioanalysis · 2023 · 11 citations · Full text

Rows per page

1–3 of 3